Pacifico Biolabs has raised Series A funding to scale its mycelium protein production using existing brewery infrastructure and expand commercial launches across the DACH region and Nordic Europe.
PacificoBiolabs, a mycelium fermentation protein company, has raised €7 million in a
Series A funding round backed by Stray Dog Capital, TGFS, Sprout & About
Ventures, Simon Capital, FoodLabs, and a regional brewery partner.
Pacifico
Biolabs develops protein ingredients using mycelium fermentation technology.
Founded in 2022, Germany’s Pacifico Biolabs has closed a €7 million Series A funding round. The food ingredient supplier has…
Bristol-and-Lisbon climate-tech firm Mykor has raised €4.6M to scale MykoFoam, a carbon-negative mycelium insulation panel grown…
StrainX Bioworks, a synthetic biology and precision fermentation startup, has raised $13 million to advance its biotechnology…
BENGALURU: Synthetic biology startup StrainX Bioworks has raised $13 million in a Series A funding round led by Prime Venture…
Mykor has raised £4M led by Clean Growth Fund and The FSE Group to scale a fungi-grown structural insulation panel that delivers…
The deal adds solid-state fermentation expertise and whole-cut product development capabilities as the Hamburg biotech company…
